Literature DB >> 2959969

Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.

Y Igarashi1, Y F Chen, J M Wyss, M D Lindheimer, S Oparil.   

Abstract

Cardiovascular responses to sustained infusion of quinpirole (LY171555), a dopamine (DA) D2 receptor agonist, and bolus injection of quinpirole following sustained infusion were examined in conscious, unrestrained Sprague-Dawley rats to investigate the contributions of central and peripheral D2 receptors to the regulation of cardiovascular function. Continuous intravenous administration of quinpirole induced a transient pressor response followed by normalization of mean arterial pressure (MAP) and, at higher doses, a decrease in MAP below control levels. Intravenous bolus injections of quinpirole administered 30 min after termination of the infusion produced dose-dependent depressor responses which were blocked by pretreatment with domperidone, a peripheral D2 antagonist. The data suggest that continuous intravenous administration of quinpirole produces a transient centrally mediated pressor effect which is followed by a more sustained, peripherally mediated depressor response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959969     DOI: 10.1159/000138311

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.

Authors:  S S Ng; C C Pang
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease.

Authors:  Gerd Luippold; Alexander Max; Margitta Albinus; Hartmut Osswald; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-23       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.